Form 4: VolitionRx Ltd: Officer Rootsaert Receives Restricted Stock Units in Lieu of Cash Compensation

Rodney Gerard Rootsaert, Secretary of VolitionRx Ltd, received 12,984 restricted stock units (RSUs) on June 1, 2024, in lieu of cash compensation.

Summary

• Rodney Gerard Rootsaert, Secretary of VolitionRx Ltd, filed a Form 4 detailing changes in beneficial ownership.
• On June 1, 2024, Rootsaert was awarded 12,984 restricted stock units (RSUs) under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation.
• The RSUs vest in three equal installments of 4,328 units on June 1, 2024, July 1, 2024, and August 1, 2024, respectively, with further time-based vesting on May 1, 2025, subject to continued service.
• Upon vesting and settlement, Rootsaert will receive shares of common stock equal to the number of RSUs that have vested.
• Rootsaert directly owns 110,336 shares of common stock and indirectly owns 1,007,718 shares through Concord International, Inc., where he is a controlling director.

Sentiment

Score: 6

Explanation: Neutral sentiment as the document is a standard regulatory filing detailing compensation. The RSU grant is a positive for the recipient but doesn't necessarily indicate a significant shift in the company's overall prospects.

Positives

• The award of RSUs to a key officer aligns their interests with the long-term performance of the company.
• The vesting schedule incentivizes continued service and commitment from the officer.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates compensation practices at VolitionRx Ltd.

Stakeholder Impact

• Shareholders may view the RSU grant as aligning management's interests with the company's performance.
• Employees may see the RSU grant as a positive sign of the company's commitment to its employees.

Key Dates